NFH Inositol SAP, 500g
*Must have Practitioner recommendation before use*
*WE MAY VERIFY THE INFORMATION GIVEN*
NFH Inositol SAP Details
Polycystic ovary syndrome (PCOS) is the most common cause of ovulatory disorders and female infertility. Signs and symptoms of PCOS may include anovulation or menstrual irregularities; ovarian cysts on ultrasound; hyperandrogenism including hirsutism, acne, and alopecia; insulin resistance; and weight issues. Insulin resistance and secondary hyperinsulinemia appear to play a causative role in the development of PCOS. Myo-inositol has been suggested as a first-line therapy in the treatment of PCOS and has been shown to be effective in mitigating the symptoms of this syndrome and its associated comorbidities.
Original: $40.96
-65%$40.96
$14.34NFH Inositol SAP, 500g
*Must have Practitioner recommendation before use*
*WE MAY VERIFY THE INFORMATION GIVEN*
NFH Inositol SAP Details
Polycystic ovary syndrome (PCOS) is the most common cause of ovulatory disorders and female infertility. Signs and symptoms of PCOS may include anovulation or menstrual irregularities; ovarian cysts on ultrasound; hyperandrogenism including hirsutism, acne, and alopecia; insulin resistance; and weight issues. Insulin resistance and secondary hyperinsulinemia appear to play a causative role in the development of PCOS. Myo-inositol has been suggested as a first-line therapy in the treatment of PCOS and has been shown to be effective in mitigating the symptoms of this syndrome and its associated comorbidities.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
*Must have Practitioner recommendation before use*
*WE MAY VERIFY THE INFORMATION GIVEN*
NFH Inositol SAP Details
Polycystic ovary syndrome (PCOS) is the most common cause of ovulatory disorders and female infertility. Signs and symptoms of PCOS may include anovulation or menstrual irregularities; ovarian cysts on ultrasound; hyperandrogenism including hirsutism, acne, and alopecia; insulin resistance; and weight issues. Insulin resistance and secondary hyperinsulinemia appear to play a causative role in the development of PCOS. Myo-inositol has been suggested as a first-line therapy in the treatment of PCOS and has been shown to be effective in mitigating the symptoms of this syndrome and its associated comorbidities.
